No Data
No Data
GENDA, HMT and others [Emerging Markets press release]
<4425>Kudan has revised its downward forecast for the current operating loss to △8.50 to △0.82 billion yen, down from △0.43 billion yen. A strategic partnership has been established with a Global company that provides services for various industries. <4892>Saifuse has recorded grant income of approximately 1.2 billion yen as non-operating income. <5248>Technologies has established a subsidiary and launched a new business. <6090>HMT has applied for a change of listing to the Standard market on the Tokyo Stock Exchange. <9166>GENDA is implementing Stock Splits, changing from 2 shares to 1 share for shareholder benefits.
Human Metabolome Technologies: Interim financial results presentation materials for the fiscal year ending June 2025
Nexon etc. announced a Share Buyback on February 13.
The following stocks announced the establishment of a share buyback program on February 13 (Thursday): <6758> Sony Group Corp 30 million shares (0.5%) 50 billion yen (from 25/2/14 to 25/5/14) <3659> Nexon 32 million shares (3.9%) 50 billion yen (from 25/2/14 to 25/6/30) <3395> Sanmarc HD 4 million shares (19.6%) 10.4 billion yen (from 25/2/14 to 25/2/28) <8113> Unicharm Corporation Sponsored ADR 25 million shares (1.4%) 22 billion yen (from 25/2/
Key points of interest for the PTS on the 13th = Sony Group Corp, Alphapoly, INFORI, Takasago International, ETC.
▽Sony Group Corp <6758.T> announced that the consolidated operating profit for the third quarter cumulative of the fiscal year ending March 2025 (April to December 2024) is 1 trillion 203.5 billion yen, an increase of 23% compared to the same period last year. The full-year performance Financial Estimates have been raised, and a share buyback program has been established. ▽ Alphapoli <9467.T> has raised its consolidated operating profit Financial Estimates for the fiscal year ending March 2025 from 2.51 billion yen to 3.09 billion yen, a 36% increase compared to the previous period. Sales of e-books are strong. The annual Dividends forecast has been increased from 11 yen to 14 yen. ▽ INFORI <9338.T>, for the fiscal year ending January 2025.
Human Metabolome Technologies Reports Robust Quarterly Growth
Human Metabolome Technologies: Half Year Report - Term 22 (2024/07/01 - 2025/06/30)